Immunovia AB announces that Philipp Mathieu has been appointed as acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated.
ADVERTISEMENT
Paris-based Onxeo S.A. has started the new year with an interim CEO. Julien Miara has taken over the position.
Gabriella Björknert Caracciolo will leave Bactiguard AB, where she currently works as CFO and deputy CEO.
Swedish Oncopeptides has had a new CEO since mid-November. Jakob Lindberg has taken over the position from Marty J. Duvall again. He has left the company.
Lund-based Immunovia will need a new CEO, because Patrik Dahlen wants to leave the diagnostics company for personal reasons.
Dr Nicolas Gaudenzio has been started at the beginning of November as Chief Scientific Officer of Genoskin.
Lotta Ferm, interim CFO of Immunicum AB, was now named as Chief Financial Officer.
BIAL, a public limited company under Portuguese law with head office in Coronado, Portugal, appointed Joerg Holenz as R&D General Manager and as a member of the Board of Directors.
Cambridge-based Mogrify Limited announced the appointment of Tom Graney CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor.
Since October, Dr. Gisèle Deblandre has strengthened the team of Cellbox Solutions GmbH in Norderstedt near Hamburg as Chief Scientific Officer.